Test Menu Category: Genomics

Genomic testing evaluates sets of genes and gene interactions with respect to disease processes and treatment, especially applied in cancer prediction, diagnostics, prognostics and treatment selection.

Pharmacogenomics (PGx) is the use of genetic information in tailoring or predicting drug response whereas Pharmacogenetics associates drug interaction with an individual's genotype.

The coupling of genomic or genetic testing with the use of FDA-approved drugs results in a companion diagnostic where the drug targets a certain marker or genetic mutation associated with a patient's response. For a current listing of FDA approved companion diagnostics click here.

Genomics Tests

PML/RARA t(15,17) by FISH

Solid Tumor 8 Gene Panel by Next Generation Sequencing

1 2 3 next →